35. Ponec M, Weerheim A, Kempenaar J, Mulder A, Gooris GS, Bouwstra J, et al. The formation of competent barrier lipids in reconstructed human epidermis requires the presence of vitamin C. J Invest Dermatol 1997; 109(3):348-355.

36. Nieman DC, Henson DA, Butterworth DE, Warren BJ, Davis JM, Fagoaga OR, et al. Vitamin C supplementation does not alter the immune response to 2.5 hours of running. Int J Sport Nutr 1997; 7:173-184.

37. de Villiers WJS, Smart EJ. Macrophage scavenger receptors and foam cell formation. J Leukoc Biol 1999; 66:740–746.

38. Li AC, Glass CK. The macrophage foam cell as a target for therapeutic intervention. Nat Med 2002; 8:1235–1242.

39. Maeng HG, Lim H, Jeong YJ, Woo A, Kang JS, Lee WJ, et al. Vitamin C enters mouse T cells as dehydroascorbic acid in vitro and does not recapitulate in vivo vitamin C effects. Immunobiology 2009; 214:311-320.

40. Welge-Lussen L, Schimmel KP. Examinations of aminoacids in aqueous humour after intravitreous injection of ascorbic acid. Klin Monatsbl Augenheilkd 1978; 172(6):824-830.

41. Varma SD, Kumar S, Richards RD. Light-induced damage to ocular lens cation pump: prevention by vitamin C. Proc Natl Acad Sci USA 1979; 76:3504-3506.

42. Vitale S, West S, Hallfrisch J, Alston C, Wang F, Moorman C, et al. Plasma antioxidants and risk of cortical and nuclear cataract. Epidemiology 1993; 4:195-203.

43. Rodríguez-Rodríguez E, Ortega RM, López-Sobaler AM, Aparicio A, Bermejo LM, Marín-Arias LI. The relationship between antioxidant nutrient intake and cataracts in older people. Int J Vitam Nutr Res 2006; 76:359-366.

44. Jalal D, Koorosh F, Fereidoun H. Comparative study of plasma ascorbic acid levels in senile cataract patients and in normal individuals. Curr Eye Res 2009; 34:118-122.

45. Nakashima Y, Sanada H, Suzue R, Kawada S. Role of ascorbic acid on tyrosine hydroxylase activity in the adrenal gland of guinea pig. J Nutr Sci Vitaminol (Tokyo) 1976; 22:355-363.

46. May JD, McNaughton JL. Effects of dietary ascorbic acid, aspirin, lysine, and thiouracil on thyroid activity. Poult Sci 1980; 59:893-899.

47. Dubin B, MacLennan WJ, Hamilton JC. Adrenal function and ascorbic acid concentrations in elderly women. Gerontology 1978; 24:473-476.

48. Voskresenskii ON, Bobyrev VN. Effect of ascorbic acid and rutin on the development of experimental peroxide atherosclerosis. Farmakol Toksikol 1979; 42:378-382.

49. Frei B. Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage. Am J Clin Nutr 1991; 54:1113S-1118S.

50. Knekt P, Reunanen A, Jarvinen R, Seppänen R, Heliövaara M, Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994; 139:1180-1189.

51. Gale CR, Martyn CN, Winter PD, Cooper C. Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. BMJ 1995; 310:1563-1566.

52. Knekt P, Ritz J, Pereira MA, O'Reilly EJ, Augustsson K, Fraser GE, et al. Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am J Clin Nutr 2004; 80:1508-1520.

53. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, et al. Vascular cell-adhesion molecule-1 (Vcam-1) gene-transcription and expression are regulated through an antioxidant sensitive mechanism in human vascular endothelial-cells. J Clin Invest 1993; 92:1866–1874.

54. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328:1450-1456.

55. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993; 328:1444-1449.

56. Ness A, Egger M, Smith GD. Role of antioxidant vitamins in prevention of cardiovascular diseases. Meta-analysis seems to exclude benefit of vitamin C supplementation. BMJ, 1999, 319:577.

57. De Keulenaer GW, Ushio-Fukai M, Yin Q, Cheng AB, Lyons PR, Ishizaka N, et al. Convergence of redox-sensitive and mitogen-activated protein kinase signaling pathways in tumor necrosis factor-alpha-mediated monocyte chemoattractant protein-1 induction in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000; 20:385–391.

58. Dimmeler S, Zeiher AM. Reactive oxygen species and vascular cell apoptosis in response to angiotensin II and pro-atherosclerotic factors. Regul Pept 2000; 90:19–25.

59. Nissen SE, Tuzcu EM, Schoenhagen P, Crowe T, Sasiela WJ, Tsai J, et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 2005; 352:29–38.

60. Forstermann U, Munzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 2006; 113:1708–1714.

61. Hudiburgh NK, Milner AN. Influence of oral contraceptives on ascorbic acid and triglyceride status. J Am Diet Assoc 1979; 75:19-22.

62. Rautalahti M, Huttunen J. Antioxidants and carcinogenesis. Ann Med 1994; 26:435-441.

63. Van Poppel G, Kardinaal A, Princen H, Kok FJ. Antioxidants and coronary heart disease. Ann Med 1994; 26:429-434.

64. Johnston CS, Cox SK. Plasma-Saturating intakes of vitamin C confer maximal antioxidant protection to plasma. J Am Coll Nutr 2001; 20:623-627.

65. Roeder RA. Beyond Deficiency: New Views of Vitamins in Ruminant Nutrition and Health: An Overview. J Nutr 1995; 125: 1790S-1791S.

66. Pocwiardowska E, Puglisi L. The effects of L-ascorbic acid and prostaglandins on isolated tracheal smooth muscle. Acta Physiol Pol 1980; 31:187-194.

67. Clemetson CA. Histamine and ascorbic acid in human blood. J Nutr 1980; 110:662-668.

68. Metz J, Hundertmark U, Pevny I. Vitamin C allergy of the delayed type. Contact Dermatitis 1980; 6:172-174.

69. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40:405–412.

70. Austin S, Hitchcock C. The Linus Pauling-Mayo Clinic controversy involving Vitamin C and cancer tests. Nutrition Health Review: The Consumer's Med J, 1994; 71:10.

71. Agus DB, Gambhir SS, Pardridge WM, Spielholz C, Baselga J, Vera JC, et al. Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters. J Clin Invest 1997; 100:2842–2848.

72. Ng LL, Ngkeekwong FC, Quinn PA, Davies JE. Uptake mechanisms for ascorbate and dehydroascorbate in lymphoblasts from diabetic nephropathy and hypertensive patients. Diabetologia 1998; 41:435–442.

73. Qutob S, Dixon SJ, Wilson JX. Insulin stimulates vitamin C recycling and ascorbate accumulation in osteoblastic cells. Endocrinology 1998; 139:51–56.

74. Korcok J, Dixon SJ, Lo TC, Wilson JX. Differential effects of glucose on dehydroascorbic acid transport and intracellular ascorbate accumulation in astrocytes and skeletal myocytes. Brain Res 2003; 993:201–207.

75. Hosoya K, Minamizono A, Katayama K, Terasaki T, Tomi M. Vitamin C transport in oxidized form across the rat blood-retinal barrier. Investig Ophthalmol Vis Sci 2004; 45:1232–1239.

76. Chen L, Jia RH, Qiu CJ, Ding G. Hyperglycemia inhibits the uptake of dehydroascorbate in tubular epithelial cell. Am J Nephrol 2005; 25:459–465.

77. Fadupin GT, Akpoghor AU, Okunade KA. A comparative study of serum ascorbic acid level in people with and without type 2 diabetes in Ibadan, Nigeria. Afr J Med Med Sci 2007; 36:335-339.

78. Cameron E, Campbell A. The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem Biol Interact 1974; 9:285–315.

79. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006; 127:679–695.

80. Chang HJ, Park JS, Lee EK, Kim MH, Baek MK, Kim HR, et al. Ascorbic Acid Suppresses the 2,3,7,8-Tetrachloridibenxo-p-dioxin (TCDD)-induced CYP1A1 Expression in Human HepG2 Cells. Toxicol In Vitro, 2009 23(4):622-626.